AfimaCheck

Toronto, Canada Founded: 2021 • Age: 5 yrs
Developer of thermal reader technology for onsite drug testing applications

About AfimaCheck

AfimaCheck is a company based in Toronto (Canada) founded in 2021 by Nima Tabatabaei. AfimaCheck offers products and services including Assay Reader and Thermophotonic Technology. AfimaCheck operates in a competitive market with competitors including Intelligent Fingerprinting, Detect, Confirm BioSciences, Safety Strips and Portable Diagnostic Systems, among others.

  • Headquarter Toronto, Canada
  • Founders Nima Tabatabaei
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website afimacheck.com
  • Social LinkedIn X
  • Legal Name Afimacheck Inc.

Products & Services of AfimaCheck

AfimaCheck offers a comprehensive portfolio of products and services, including Assay Reader and Thermophotonic Technology.

Assay Reader
Diagnostic Device

Improves LFA sensitivity for accurate drug and disease detection

Thermophotonic Technology
Testing Enhancement

Enables quantitative measurements on existing Lateral Flow Assays

People of AfimaCheck

2 people are tracked at AfimaCheck (2 in leadership).

NameRoleGroup
Nima Tabatabaei
Founder & CTOLeadership
Chris Schwartze
CEOLeadership
Premium access

Complete people profiles for AfimaCheck

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of AfimaCheck

AfimaCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intelligent Fingerprinting, Detect, Confirm BioSciences, Safety Strips and Portable Diagnostic Systems, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
intelligentfingerprinting.com2007Cambridge, United Kingdom$25.71M35
Non-invasive drug testing technology is developed using fingerprints.
detect.com1996Guilford, United States––
Diagnostics for women’s health are transformed through innovative solutions.
confirmbiosciences.com2008San Diego, United States–35
Tools and solutions for drug and health testing are provided.
safetystrips.com2005Los Angeles, United States––
Fentanyl test strips are supplied for harm reduction efforts.
portabledx.com2019Newark, United States––
Developer of drug screening device for medical exams and law enforcement
tachmed.com2018Wilmslow, United Kingdom––
Offers digital devices for at-home health monitoring, diagnosis, and data sharing services.
sunbiomed.com1993La Verne, United States––
Developer of in-vitro diagnostics for drug abuse detection
aftslabs.com2011New York, United States––
Provider of drug testing methods for substance abuse and pain management
Premium access

Detailed competitors of AfimaCheck

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to AfimaCheck

10 companies that operate in the same segment as AfimaCheck (Toxicology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutic solutions for food allergies are developed via antibody platforms.
2019San Francisco, California, United StatesUSD 75 M––
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
2020Oakland, California, United StatesUSD 70 M––
Drug delivery solutions via single-walled carbon nanotubes are offered.
2008Houston, Texas, United StatesUSD 2.5 MUSD 5.07 M9
Non-invasive drug testing technology is developed using fingerprints.
2007Cambridge, Cambridgeshire, United KingdomUSD 25.71 M––
Provides toxicology, chemistry, and consultancy services for agrochemical industries.
2020Vapi, Gujarat, India–––
Instruments for rapid human DNA identification are developed.
2006Pleasanton, California, United StatesUSD 92.06 MUSD 22.5 B78
Oral therapies for snake bite treatment are developed.
2015Corte Madera, California, United StatesUSD 16.48 M––
Quantitative urine drug testing is provided for patient monitoring.
2011San Diego, California, United States––358
Point-of-care platforms for heavy metal toxicity diagnostics are developed.
1968Billerica, Massachusetts, United StatesUSD 34 M––
Real-time trace gas analysis solutions are delivered using SIFT-MS technology.
2002Christchurch, New ZealandUSD 11.9 MUSD 23.52 M–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AfimaCheck

AfimaCheck was founded in 2021.

AfimaCheck is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Chris Schwartze is the current CEO of AfimaCheck.

AfimaCheck was founded in 2021 in Toronto, Canada, within the health technology sector. Thermal reader technology is developed for onsite applications, including the AfimaCheck Reader, which detects drugs of abuse in saliva for safety-sensitive roles. Photothermal detection methods are employed, utilizing laser stimulation and infrared sensors to quantify SARS-CoV-2 antibodies. Operations focus on rapid, reliable testing solutions for various professional environments.

AfimaCheck's top competitors include Intelligent Fingerprinting, Safety Strips and Confirm BioSciences.

AfimaCheck offers Assay Reader and Thermophotonic Technology.

AfimaCheck operates through Afimacheck Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available